First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04000282

Recruitment Status : Terminated (Terminated based on sponsor decision (for reasons unrelated to safety, in reviewing Sponsor's evolving portfolio and strategic prioritization))

First Posted : June 27, 2019

Last Update Posted : September 21, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Sanofi

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	August 29, 2022
Actual Study Completion Date :	September 4, 2023

To Top